Protective and therapeutic effectiveness of taurine in diabetes mellitus: A rationale for antioxidant supplementation

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 1, 2015, Pages 55-64

  Sirdah, Mahmoud M ^a  

^a AL AZHAR UNIVERSITY   (Palestine)

Author keywords

Antioxidants; Complications; Diabetes mellitus; Oxidative stress; Taurine

Indexed keywords

TAURINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT;

DIABETES MELLITUS; DIABETIC FOOT; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DRUG EFFICACY; FOOT ULCER; GANGRENE; HUMAN; HYPERGLYCEMIA; INTESTINE ABSORPTION; KIDNEY FAILURE; NEUROTRANSMISSION; NONHUMAN; NONKETOTIC DIABETIC COMA; OSMOREGULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; DRUG EFFECTS; HOMEOSTASIS; INFLAMMATION; METABOLISM;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; INFLAMMATION; OXIDATIVE STRESS; TAURINE;

EID: 84920729871     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.05.001     Document Type: Review

References (157)

1. F. Tiedemann, and L. Gmelin Einige neue Bestandtheile der Galle des Ochsen Ann Phys 85 2 1827 326 337
2. H. Demarcay Uber die Natur der Galle Ann Pharm 27 3 1838 270 291
3. R.J. Huxtable Physiological actions of taurine Physiol Rev 72 1992 101 163
4. R.J. Huxtable Taurine. Past, present, and future Adv Exp Med Biol 403 1996 641 650
5. S.S. Oja, and P. Saransaari Pharmacology of taurine Proc West Pharmacol Soc 50 2007 8 15
6. Y.J. Xu, A.S. Arneja, P.S. Tappia, and N.S. Dhalla The potential health benefits of taurine in cardiovascular disease Exp Clin Cardiol 13 2008 57 65
7. S.W. Schaffer, C.J. Jong, K.C. Ramila, and J. Azuma Physiological roles of taurine in heart and muscle J Biomed Sci 17 Suppl. 1 2010 S2
8. J.Y. Wu, and H. Prentice Role of taurine in the central nervous system J Biomed Sci 17 Suppl. 1 2010 S1
9. Y. Yamori, T. Taguchi, A. Hamada, K. Kunimasa, H. Mori, and M. Mori Taurine in health and diseases: consistent evidence from experimental and epidemiological studies J Biomed Sci 17 Suppl. 1 2010 S6
10. W. Abebe, and M.S. Mozaffari Role of taurine in the vasculature: an overview of experimental and human studies Am J Cardiovasc Dis 1 2011 293 311
11. A. Zulli Taurine in cardiovascular disease Curr Opin Clin Nutr Metab Care 14 2011 57 60
12. J. Menzie, C. Pan, H. Prentice, and J.Y. Wu Taurine and central nervous system disorders Amino Acids 46 2014 31 46
13. H. Ripps, and W. Shen Review: taurine: a "very essential" amino acid Mol Vis 18 2012 2673 2686
14. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
15. M. Roden Diabetes mellitus: definition, classification and diagnosis Wien Klin Wochenschr 124 Suppl. 2 2012 1 3
16. American Diabetes, and Association Diagnosis and classification of diabetes mellitus Diabetes Care 36 Suppl. 1 2013 S67 S74
17. A.C. Maritim, R.A. Sanders, and J.B. Watkins 3rd Diabetes, oxidative stress, and antioxidants: a review J Biochem Mol Toxicol 17 2003 24 38
18. F. Franconi, F. Bennardini, A. Mattana, M. Miceli, M. Ciuti, and M. Mian Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation Am J Clin Nutr 61 1995 1115 1119
19. F. Franconi, M. Miceli, A. Fazzini, G. Seghieri, S. Caputo, and M.A. DiLeo Taurine and diabetes. Humans and experimental models Adv Exp Med Biol 403 1996 579 582
20. F. Franconi, M.A. Di Leo, F. Bennardini, and G. Ghirlanda Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 29 2004 143 150
21. W.T. Cade Diabetes-related microvascular and macrovascular diseases in the physical therapy setting Phys Ther 88 2008 1322 1335
22. M. Fowler Microvascular and macrovascular complications of diabetes Clin Diabetes 26 2 2008 77 82
23. F.B. Hamdan, and H.Y. Al-Matubsi Assessment of erectile dysfunction in diabetic patients Int J Androl 32 2009 176 185
24. W.K. Owiredu, N. Amidu, H. Alidu, C. Sarpong, and C.K. Gyasi-Sarpong Determinants of sexual dysfunction among clinically diagnosed diabetic patients Reprod Biol Endocrinol 9 2011 70
25. M.S. Amer, M.A. Alsadany, M.F. Tolba, and O.H. Omar Quality of life in elderly diabetic patients with peripheral arterial disease Geriatr Gerontol Int 13 2013 443 450
26. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
27. P. Zhang, X. Zhang, J. Brown, D. Vistisen, R. Sicree, and J. Shaw Global healthcare expenditure on diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 2010 293 301
28. J.W. Baynes, and S.R. Thorpe Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 48 1999 1 9
29. P. Goycheva, V. Gadjeva, and P. Popov Oxidative stress and its complications in diabetes mellitus Trakia J Sci 4 1 2006 1 8
30. W. Wei, Q. Liu, Y. Tan, L. Liu, X. Li, and L. Cai Oxidative stress, diabetes, and diabetic complications Hemoglobin 33 2009 370 377
31. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ Res 107 2010 1058 1070
32. B. Halliwell Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344 1994 721 724
33. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
34. R.P. Robertson Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes J Biol Chem 279 2004 42351 42354
35. R. Robertson, H. Zhou, T. Zhang, and J.S. Harmon Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes Cell Biochem Biophys 48 2007 139 146
36. T.P. Devasagayam, J.C. Tilak, K.K. Boloor, K.S. Sane, S.S. Ghaskadbi, and R.D. Lele Free radicals and antioxidants in human health: current status and future prospects J Assoc Phys India 52 2004 794 804
37. J.S. Johansen, A.K. Harris, D.J. Rychly, and A. Ergul Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice Cardiovasc Diabetol 4 2005 5
38. D. Demeyer, K. Raes, V. Fievez, and S. De Smet Radicals and antioxidants in relation to human and animal health: a case for functional feeding Commun Agric Appl Biol Sci 69 2004 75 91
39. B. Halliwell Antioxidants in human health and disease Annu Rev Nutr 16 1996 33 50
40. G. De Luca, P.R. Calpona, A. Caponetti, G. Romano, A. Di Benedetto, and D. Cucinotta Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients Metabolism 50 2001 60 64
41. J. Martensson, and G. Hermansson Sulfur amino acid metabolism in juvenile-onset nonketotic and ketotic diabetic patients Metabolism 33 1984 425 428
42. S.H. Hansen The role of taurine in diabetes and the development of diabetic complications Diabetes Metab Res Rev 17 2001 330 346
43. M. Merheb, R.T. Daher, M. Nasrallah, R. Sabra, F.N. Ziyadeh, and K. Barada Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study Diabetes Care 30 2007 2652 2654
44. S.J. Kim, C. Ramesh, H. Gupta, and W. Lee Taurine-diabetes interaction: from involvement to protection J Biol Regul Homeost Agents 21 2007 63 77
45. H.O. Goodman, and Z.K. Shihabi Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides Biochem Med Metab Biol 43 1990 1 9
46. D.K. Reibel, J.E. Shaffer, J.J. Kocsis, and J.R. Neely Changes in taurine content in heart and other organs of diabetic rats J Mol Cell Cardiol 11 1979 827 830
47. H. Trachtman, P. Lu, and J.A. Sturman Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states J Histochem Cytochem 41 1993 1209 1216
48. C. Vilchis, and R. Salceda Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium Neurochem Res 21 1996 1167 1171
49. J.I. Malone, S.A. Benford, and J. Malone Jr. Taurine prevents galactose-induced cataracts J Diabetes Complications 7 1993 44 48
50. M.J. Stevens, S.A. Lattimer, M. Kamijo, C. Van Huysen, A.A. Sima, and D.A. Greene Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat Diabetologia 36 1993 608 614
51. R. Pop-Busui, K.A. Sullivan, C. Van Huysen, L. Bayer, X. Cao, and R. Towns Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits Exp Neurol 168 2001 259 272
52. K.C. Hayes, R.E. Carey, and S.Y. Schmidt Retinal degeneration associated with taurine deficiency in the cat Science 188 1975 949 951
53. P.D. Pion, M.D. Kittleson, Q.R. Rogers, and J.G. Morris Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy Science 237 1987 764 768
54. J.A. Sturman Dietary taurine and feline reproduction and development J Nutr 121 1991 S166 S170
55. T. Ito, S.W. Schaffer, and J. Azuma The potential usefulness of taurine on diabetes mellitus and its complications Amino Acids 42 2012 1529 1539
56. M.L. Marcovecchio, M. Lucantoni, and F. Chiarelli Role of chronic and acute hyperglycemia in the development of diabetes complications Diabetes Technol Ther 13 2011 389 394
57. D. Ackerman, and H.A. Heinsen Uber die physiologische wirkung des asterubins and anderer, zum tiel neu dargestellter, schwefelhaltiger guanidinderivate Z Physiol Chem 235 1935 115 121
58. A.B. Macallum, and C. Sivertz The potentiation of insulin by sulfones Can Chem Process 26 1942 669
59. G. Donadio, and P. Fromageot Influence exerted by taurine on the utilization of glucose by the rat Bull Soc Chim Biol (Paris) 46 1964 293 302
60. G.A. Dokshina, T. Silaeva, and E.I. Lartsev Insulin-like effects of taurine Vopr Med Khim 22 1976 503 507
61. E.C. Kulakowski, and Maturo Hypoglycemic properties of taurine: not mediated by enhanced insulin release Biochem Pharmacol 33 1984 2835 2838
62. T.E. Tenner Jr., X.J. Zhang, and J.B. Lombardini Hypoglycemic effects of taurine in the alloxan-treated rabbit, a model for type 1 diabetes Adv Exp Med Biol 526 2003 97 104
63. J. Das, V. Vasan, and P.C. Sil Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis Toxicol Appl Pharmacol 258 2012 296 308
64. W.G. Lampson, J.H. Kramer, and S.W. Schaffer Potentiation of the actions of insulin by taurine Can J Physiol Pharmacol 61 1983 457 463
65. E.C. Kulakowski, and J. Maturo Does taurine bind to the insulin binding site of the insulin receptor? Prog Clin Biol Res 351 1990 95 102
66. N. Alvarado-Vasquez, P. Zamudio, E. Ceron, B. Vanda, E. Zenteno, and G. Carvajal-Sandoval Effect of glycine in streptozotocin-induced diabetic rats Comp Biochem Physiol C: Toxicol Pharmacol 134 2003 521 527
67. P. Odetti, C. Pesce, N. Traverso, S. Menini, E.P. Maineri, and L. Cosso Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 52 2003 499 505
68. M.A. Di Leo, S.A. Santini, N.G. Silveri, B. Giardina, F. Franconi, and G. Ghirlanda Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats Amino Acids 27 2004 187 191
69. X.D. Song, C.Z. Chen, B. Dong, Y.Y. Shi, W. Zhang, and L.S. Yan Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts Zhonghua Yan Ke Za Zhi Chin J Ophthalmol 39 2003 605 609
70. E. Lim, S. Park, and H. Kim Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice Adv Exp Med Biol 442 1998 99 103
71. L.K. Gavrovskaya, O.V. Ryzhova, A.F. Safonova, A.K. Matveev, and N.S. Sapronov Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus Bull Exp Biol Med 146 2008 226 228
72. K. Winiarska, K. Szymanski, P. Gorniak, M. Dudziak, and J. Bryla Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits Biochimie 91 2009 261 270
73. J. Han, J.H. Bae, S.Y. Kim, H.Y. Lee, B.C. Jang, and I.K. Lee Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism Am J Physiol Endocrinol Metab 287 2004 1008 1018
74. A. El Idrissi, L. Boukarrou, and W. L'Amoreaux Taurine supplementation and pancreatic remodeling Adv Exp Med Biol 643 2009 353 358
75. H.O. El Mesallamy, E. El-Demerdash, L.N. Hammad, and H.M. El Magdoub Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance Diabetol Metab Syndr 2 2010 46
76. N. Harada, C. Ninomiya, Y. Osako, M. Morishima, K. Mawatari, and A. Takahashi Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats Obes Res 12 2004 1077 1084
77. Y. Nakaya, A. Minami, N. Harada, S. Sakamoto, Y. Niwa, and M. Ohnaka Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes Am J Clin Nutr 71 2000 54 58
78. A.T. Nandhini, V. Thirunavukkarasu, M.K. Ravichandran, and C.V. Anuradha Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats Singapore Med J 46 2005 82 87
79. E.P. Elizarova, and L.V. Nedosugova First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes Adv Exp Med Biol 403 1996 583 588
80. K.B. Chauncey, T.E. Tenner Jr., J.B. Lombardini, B.G. Jones, M.L. Brooks, and R.D. Warner The effect of taurine supplementation on patients with type 2 diabetes mellitus Adv Exp Med Biol 526 2003 91 96
81. C. Brons, C. Spohr, H. Storgaard, J. Dyerberg, and A. Vaag Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus Eur J Clin Nutr 58 2004 1239 1247
82. C. Xiao, A. Giacca, and G.F. Lewis Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men Diabetologia 51 2008 139 146
83. S. Hansen, and O. Mortensen Taurine and metabolic disease A. El Idrissi, W. L'Amoreaux, Taurine in health and disease 2012 Transworld Research Network Kerala, India 167 190
84. B.K. Tripathi, and A.K. Srivastava Diabetes mellitus: complications and therapeutics Med Sci Monit 12 2006 RA130 RA147
85. M.C. Brindisi, B. Bouillet, B. Verges, and S. Halimi Cardiovascular complications in type 1 diabetes mellitus Diabetes Metab 36 2010 341 344
86. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006 World Health Organization Geneva, Switzerland
87. A.T. Reutens, and R.C. Atkins Epidemiology of diabetic nephropathy Contrib Nephrol 170 2011 1 7
88. A.K. Sharma, D.S. Kanawat, A. Mishra, P.K. Dhakad, P. Sharma, and V. Srivastava Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats J Renin Angiotensin Aldosterone Syst 2013 10.1177/1470320313475908
89. J.S. Cameron The discovery of diabetic nephropathy: from small print to centre stage J Nephrol 19 Suppl. 10 2006 S75 S87
90. A. Ntemka, F. Iliadis, N. Papanikolaou, and D. Grekas Network-centric analysis of genetic predisposition in diabetic nephropathy Hippokratia 15 2011 232 237
91. R. Wenzel, E. Ritz, and M. Wenzel Endothelin receptor antagonists in diabetic nephropathy Eur Nephrol 6 1 2012 38 41
92. M.E. Molitch, R.A. DeFronzo, M.J. Franz, W.F. Keane, C.E. Mogensen, and H.H. Parving Nephropathy in diabetes Diabetes Care 27 Suppl. 1 2004 S79 S83
93. S. Dronavalli, I. Duka, and G.L. Bakris The pathogenesis of diabetic nephropathy Nat Clin Pract Endocrinol Metab 4 2008 444 452
94. G. Wolf New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology Eur J Clin Invest 34 2004 785 796
95. G. Vinod Pathophysiology of diabetic nephropathy Clin Queries Nephrol 1 2 2012 121 126
96. N. Vasavada, and R. Agarwal Role of oxidative stress in diabetic nephropathy Adv Chronic Kidney Dis 12 2005 146 154
97. J.M. Forbes, M.T. Coughlan, and M.E. Cooper Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
98. J.M. Forbes, and M.E. Cooper Glycation in diabetic nephropathy Amino Acids 42 2012 1185 1192
99. J.M. Forbes, and M.E. Cooper Mechanisms of diabetic complications Physiol Rev 93 2013 137 188
100. R.A. DeFronzo Diabetic nephropathy: etiologic and therapeutic considerations Diabetes Rev 3 1995 510 564
101. C.E. Mogensen, W.F. Keane, P.H. Bennett, G. Jerums, H.H. Parving, and P. Passa Prevention of diabetic renal disease with special reference to microalbuminuria Lancet 346 1995 1080 1084
102. X. Han, and R.W. Chesney The role of taurine in renal disorders Amino Acids 43 2012 2249 2263
103. M. Amiry-Moghaddam, E. Nagelhus, and O.P. Ottersen Light- and electronmicroscopic distribution of taurine, an organic osmolyte, in rat renal tubule cells Kidney Int 45 1994 10 22
104. H. Trachtman, S. Futterweit, J. Maesaka, C. Ma, E. Valderrama, and A. Fuchs Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats Am J Physiol 269 1995 F429 F438
105. H. Ha, M.R. Yu, and K.H. Kim Melatonin and taurine reduce early glomerulopathy in diabetic rats Free Radic Biol Med 26 1999 944 950
106. D. Verzola, M.B. Bertolotto, B. Villaggio, L. Ottonello, F. Dallegri, and G. Frumento Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells J Investig Med 50 2002 443 451
107. D. Koya, K. Hayashi, M. Kitada, A. Kashiwagi, R. Kikkawa, and M. Haneda Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats J Am Soc Nephrol 14 2003 S250 S253
108. E. Arany, B. Strutt, P. Romanus, C. Remacle, B. Reusens, and D.J. Hill Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice Diabetologia 47 2004 1831 1837
109. E.A. Lee, J.Y. Seo, Z. Jiang, M.R. Yu, M.K. Kwon, and H. Ha Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney Kidney Int 67 2005 1762 1771
110. J.S. Huang, L.Y. Chuang, J.Y. Guh, Y.J. Huang, and M.S. Hsu Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells Am J Physiol Renal Physiol 293 2007 1072 1082
111. J.S. Huang, L.Y. Chuang, J.Y. Guh, Y.L. Yang, and M.S. Hsu Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells Toxicol Appl Pharmacol 233 2008 220 226
112. S. Higo, S. Miyata, Q.Y. Jiang, R. Kitazawa, S. Kitazawa, and M. Kasuga Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats Kobe J Med Sci 54 2008 E35 E45
113. L. Wang, L. Zhang, Y. Yu, Y. Wang, and N. Niu The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression Ren Fail 30 2008 763 771
114. J.W. Yau, S.L. Rogers, R. Kawasaki, E.L. Lamoureux, J.W. Kowalski, and T. Bek Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 2012 556 564
115. American Diabetes Association Diabetic retinopathy Diabetes Care 25 S1 2002 S90 S93
116. D.S. Fong, L.P. Aiello, F.L. Ferris 3rd, and R. Klein Diabetic retinopathy Diabetes Care 27 2004 2540 2553
117. R. Klein, and B. Klein Vision disorders in diabetes National Diabetes Data Group, Diabetes in America 2nd ed. 1995 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 293 337
118. X. Zhang, J.B. Saaddine, C.F. Chou, M.F. Cotch, Y.J. Cheng, and L.S. Geiss Prevalence of diabetic retinopathy in the United States, 2005-2008 JAMA 304 2010 649 656
119. S. Bulley, Y. Liu, H. Ripps, and W. Shen Taurine activates delayed rectifier Kv channels via a metabotropic pathway in retinal neurons J Physiol 591 2013 123 132
120. K. Zeng, H. Xu, M. Mi, Q. Zhang, Y. Zhang, and K. Chen Dietary taurine supplementation prevents glial alterations in retina of diabetic rats Neurochem Res 34 2009 244 254
121. K. Zeng, H. Xu, K. Chen, J. Zhu, Y. Zhou, and Q. Zhang Effects of taurine on glutamate uptake and degradation in Muller cells under diabetic conditions via antioxidant mechanism Mol Cell Neurosci 45 2010 192 199
122. + ATPase impairment in the retina of diabetic rats Amino Acids 23 2002 401 406
123. M.K. Song, B.D. Roufogalis, and T.H. Huang Reversal of the caspase-dependent apoptotic cytotoxicity pathway by taurine from Lycium barbarum (Goji Berry) in human retinal pigment epithelial cells: potential benefit in diabetic retinopathy Evid Based Complementary Altern Med 2012 323784
124. K. Chen, Q. Zhang, J. Wang, F. Liu, M. Mi, and H. Xu Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction Brain Res 1279 2009 131 138
125. N. Froger, F. Jammoul, D. Gaucher, L. Cadetti, H. Lorach, and J. Degardin Taurine is a crucial factor to preserve retinal ganglion cell survival Adv Exp Med Biol 775 2013 69 83
126. B.C. Callaghan, H.T. Cheng, C.L. Stables, A.L. Smith, and E.L. Feldman Diabetic neuropathy: clinical manifestations and current treatments Lancet Neurol 11 2012 521 534
127. B.C. Callaghan, J. Hur, and E.L. Feldman Diabetic neuropathy: one disease or two? Curr Opin Neurol 25 2012 536 541
128. A. Vinik, J. Ullal, H.K. Parson, and C.M. Casellini Diabetic neuropathies: clinical manifestations and current treatment options Nat Clin Pract Endocrinol Metab 2 2006 269 281
129. C.M. Casellini, and A.I. Vinik Clinical manifestations and current treatment options for diabetic neuropathies Endocr Pract 13 2007 550 566
130. V. Bril Treatments for diabetic neuropathy J Peripher Nerv Syst 17 Suppl. 2 2012 22 27
131. B.A. Perkins, and V. Bril Diabetic neuropathy: a review emphasizing diagnostic methods Clin Neurophysiol 114 2003 1167 1175
132. K.L. Farmer, C. Li, and R.T. Dobrowsky Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev 64 2012 880 900
133. T. Askwith, W. Zeng, M.C. Eggo, and M.J. Stevens Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy Am J Physiol Endocrinol Metab 297 2009 E620 E628
134. I.G. Obrosova, L. Fathallah, and M.J. Stevens Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy Exp Neurol 172 2001 211 219
135. T. Askwith, W. Zeng, M.C. Eggo, and M.J. Stevens Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells Exp Neurol 233 2012 154 162
136. F. Li, I.G. Obrosova, O. Abatan, D. Tian, D. Larkin, and E.L. Stuenkel Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats Am J Physiol Endocrinol Metab 288 2005 E29 E36
137. T. Terada, K. Hara, Y. Haranishi, and T. Sata Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain Can J Anaesth 58 2011 630 637
138. S.M. Marshall, and A. Flyvbjerg Prevention and early detection of vascular complications of diabetes BMJ 333 2006 475 480
139. E.L. Johnson Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications Adv Exp Med Biol 771 2012 139 154
140. Diabetes Control and Complication Trial (DCCT) Research Group The effect 2 of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
141. Centers for Disease Control and Prevention National Diabetes Fact Sheet 2011 http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf
142. M.E. Carr Diabetes mellitus: a hypercoagulable state J Diabetes Complications 15 2001 44 54
143. R. Aras, J.R. Sowers, and R. Arora The proinflammatory and hypercoagulable state of diabetes mellitus Rev Cardiovasc Med 6 2005 84 97
144. A.S. De Vriese, T.J. Verbeuren, J. Van de Voorde, N.H. Lameire, and P.M. Vanhoutte Endothelial dysfunction in diabetes Br J Pharmacol 130 2000 963 974
145. C. Rask-Madsen, and G.L. King Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes Nat Clin Pract Endocrinol Metab 3 2007 46 56
146. C. De la Puerta, F.J. Arrieta, J.A. Balsa, J.I. Botella-Carretero, I. Zamarron, and C. Vazquez Taurine and glucose metabolism: a review Nutr Hosp 25 2010 910 919
147. J.D. Militante, J.B. Lombardini, and S.W. Schaffer The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus Cardiovasc Res 46 2000 393 402
148. A. Frustaci, J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, and A. Maseri Myocardial cell death in human diabetes Circ Res 87 2000 1123 1132
149. M. Azuma, K. Takahashi, T. Fukuda, Y. Ohyabu, I. Yamamoto, and S. Kim Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes Eur J Pharmacol 403 2000 181 188
150. J. Das, A. Roy, and P.C. Sil Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review Food Funct 3 2012 1251 1264
151. C.S. Ahn Effect of taurine supplementation on plasma homocysteine levels of the middle-aged Korean women Adv Exp Med Biol 643 2009 415 422
152. P.S. Tappia, J. Thliveris, Y.J. Xu, N. Aroutiounova, and N.S. Dhalla Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes Exp Clin Cardiol 16 2011 e17 e22
153. M.A. Moloney, R.G. Casey, D.H. O'Donnell, P. Fitzgerald, C. Thompson, and D.J. Bouchier-Hayes Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics Diab Vasc Dis Res 7 2010 300 310
154. L.J. Wang, Y.H. Yu, L.G. Zhang, Y. Wang, N. Niu, and Q. Li Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas Eur J Pharmacol 597 2008 75 80
155. B. Dokken The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids Diabetes Spectr 21 3 2008 160 165
156. W. Chen, J.X. Guo, and P. Chang The effect of taurine on cholesterol metabolism Mol Nutr Food Res 56 2012 681 690
157. S. Murakami Taurine and atherosclerosis Amino Acids 2012 10.1007/s00726-012-1432-6